Medtronic plc (MDT) announced intent to acquire SPR Therapeutics, Inc. (SPR), a privately held medical technology company. The transaction consists of an upfront cash payment of approximately $650 million for all the outstanding equity in SPR. The anticipated close date will fall within the first half of Medtronic's fiscal 2027, which officially began on April 25, 2026.
SPR is a medical technology company focused on advancing minimally invasive therapies for the treatment of pain. Its SPRINT PNS System is designed to deliver short-term peripheral nerve stimulation therapy for sustained pain relief.
In pre-market trading on NYSE, Medtronic shares are up 0.43 percent to $78.90.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.